Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?
COVID-19 pandemic is posing an unprecedented sanitary threat: antiviral and host-directed medications to treat the disease are urgently needed. A great effort has been paid to find drugs and treatments for hospitalized, severely ill patients. However, medications used for the domiciliary management...
Saved in:
Main Authors: | Piero Sestili (Author), Carmela Fimognari (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Commentary: Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?
by: Sergio Verd, et al.
Published: (2021) -
Janus Kinase Inhibitors and Coronavirus Disease (COVID)-19: Rationale, Clinical Evidence and Safety Issues
by: Milo Gatti, et al.
Published: (2021) -
The Role of Glutathione in Protecting against the Severe Inflammatory Response Triggered by COVID-19
by: Francesca Silvagno, et al.
Published: (2020) -
Consumption of paracetamol during pregnancy
by: B. Castillo Barrio, et al.
Published: (2020) -
Repositioning Chromones for Early Anti-inflammatory Treatment of COVID-19
by: Piero Sestili, et al.
Published: (2020)